A Mutation Discovered in Iceland that Increases Risks of Osteoporosis and Certain Cancers

May 5, 2013 | NEWS

Nature Published Study Illustrates Value of Big Data Research Methods deCODE genetics (an Amgen subsidiary) and Illumina, global leaders in analyzing and understanding the human genome, together with scientists from the National Hospital of Iceland and the University...

Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics

Dec 12, 2012 | NEWS

deCODE Genetics Will Provide Amgen With an Industry-Leading Ability to Identify and Validate Disease Targets in Human Populations THOUSAND OAKS, Calif. and REYKJAVIK, Iceland, Dec. 10, 2012 /PRNewswire/ — Amgen (NASDAQ:AMGN) and deCODE Genetics today announced...

deCODE Genetics, Multinational Research Team Find Gene Variant Conferring High Risk for Common, Late-Onset Form of Alzheimer’s Disease

Nov 14, 2012 | NEWS

Findings Published in New England Journal of Medicine Provide New Focus for Drug Discovery Study Demonstrates Power of “Big Data” Research REYKJAVIK, Iceland – deCODE Genetics and Illumina, global leaders in analyzing and understanding the human genome, together...

deCODE Genetics Study Finds Father’s Age—Not Mother’s Critical to New Mutations Passed to Offspring

Aug 23, 2012 | NEWS

Nature Published Study Signals Rise in Autism Spectrum Disorder May Be Partially Tied to Increasing Age of Fathers at Time When Children are Conceived deCODE Genetics, a global leader in analyzing and understanding the human genome, in collaboration with Illumina, a...

deCODE Genetics Discovers Mutation Conferring Protection Against Alzheimer’s Disease and Cognitive Decline in Elderly

Jul 11, 2012 | NEWS

Study Indicates Link Between Age-Related Cognitive Decline and Alzheimer’s Disease Results Support Drug Development of BACE1 Inhibitors for Alzheimer’s Disease Reykjavik, ICELAND, July 11, 2012 – deCODE Genetics, a global leader in analyzing and understanding the...